` 1093 (CSPC Pharmaceutical Group Ltd) vs Hang Seng (Hong Kong) Comparison - Alpha Spread

1093
vs
Hang Seng (Hong Kong)

Over the past 12 months, has underperformed Hang Seng (Hong Kong), delivering a return of -20% compared to the Hang Seng (Hong Kong)'s 38% growth.

Stocks Performance
1093 vs Hang Seng (Hong Kong)

Loading

Performance Gap
1093 vs Hang Seng (Hong Kong)

Sign Up to see
Performance Gap
Sign In
Sign Up

Performance By Year
1093 vs Hang Seng (Hong Kong)

Loading
1093
Hang Seng (Hong Kong)
Add Stock

Competitors Performance
CSPC Pharmaceutical Group Ltd vs Peers

Hang Seng (Hong Kong)
1093
LLY
JNJ
NOVO B
ROG
Add Stock

CSPC Pharmaceutical Group Ltd
Glance View

Market Cap
60.2B HKD
Industry
Pharmaceuticals

CSPC Pharmaceutical Group Ltd., a prominent player in the pharmaceutical industry, has charted a strategic path focused on innovation and a diversified portfolio. The company, with its roots in China, has emerged as a formidable force by blending traditional pharmaceutical manufacturing with a strong emphasis on research and development. CSPC's journey is characterized by a commitment to developing high-quality generic drugs, innovative therapeutics, and nutritional products. The company's core business revolves around the production and sale of a wide range of pharmaceuticals, including cardiovascular drugs, oncology treatments, and central nervous system therapies. By leveraging advanced technology and robust research initiatives, CSPC consistently delivers solutions that address both common and complex healthcare needs across the globe. With a strategic focus on both domestic and international markets, CSPC Pharmaceutical Group capitalizes on its extensive distribution network to maximize reach and impact. The company has made significant investments in its production capabilities to maintain stringent quality standards while achieving cost efficiency. Furthermore, CSPC's earnings are bolstered by its expanding pipeline of innovative drugs, developed in-house and through strategic collaborations, which aims to capture emerging therapeutic areas. Overall, CSPC's blend of traditional pharmaceutical expertise, a focus on innovation, and strategic market positioning enables it to maintain a strong operational foothold and to consistently drive revenue growth in an ever-evolving industry landscape.

CSPC Pharmaceutical Group Ltd Intrinsic Value
HIDDEN
Show
Back to Top